English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 19 Help

Selected(0)Clear Items/Page:    Sort:
hESC-derived MSCs for clinical trials, developmental study, and cancer research Presentation
会议地点: Guiyang, 会议日期: 2024-07, 报告日期: 2024-07-01
Authors:  XU REN HE
Favorite |  | Submit date：2024/07/17
Hesc-derived Mscs, Clinical Trials, Developmental Study, Cancer Research  
Blockage of Autophagy for Cancer Therapy: A Comprehensive Review Journal article
Hassan, Ahmed Mostafa Ibrahim Abdelrahman, Zhao, Yuxin, Chen, Xiuping, He, Chengwei. Blockage of Autophagy for Cancer Therapy: A Comprehensive Review[J]. International Journal of Molecular Sciences, 2024, 25(13).
Authors:  Hassan, Ahmed Mostafa Ibrahim Abdelrahman;  Zhao, Yuxin;  Chen, Xiuping;  He, Chengwei
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.9/5.6 | Submit date：2024/10/10
autophagy inhibitors  cancer therapy  clinical trials  
Blockage of Autophagy for Cancer Therapy: A Comprehensive Review Review article
2024
Authors:  Hassan, Ahmed Mostafa Ibrahim Abdelrahman;  Zhao, Yuxin;  Chen, Xiuping;  He, Chengwei
Adobe PDF | Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.9/5.6 | Submit date：2024/08/05
Autophagy Inhibitors  Cancer Therapy  Clinical Trials  
Characteristics of clinical trials of new oncology drugs approved in China Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:  Yang, Jing;  Yang, Ji;  Hu, Yuan Jia
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/05/16
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials Journal article
Zhang, Daiyan, Lyu, Liyang, Han, Shuo, Xu, Jiaqi, Hu, Guang, Zhao, Qi, Hu Yuanjia. Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials[J]. International Immunopharmacology, 2024, 126, 111273.
Authors:  Zhang, Daiyan;  Lyu, Liyang;  Han, Shuo;  Xu, Jiaqi;  Hu, Guang; et al.
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.8/5.0 | Submit date：2024/01/02
Car-t  Clinical Trials  Dual-target  Target Profiling  
Characteristics of clinical trials of new oncology drugs approved in China Review article
2023
Authors:  Jing Yang;  Ji Yang;  HU YUANJIA
Adobe PDF | Favorite | TC[WOS]:1 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/01/02
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Pharmacological therapies and drug development targeting SARS-CoV-2 infection Review article
2022
Authors:  Yizhou Jiang;  Limor Rubin;  Zhiwei Zhou;  Haibo Zhang;  Qiaozhu Su; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:9.3/10.2 | Submit date：2023/01/30
Clinical Trials  Covid-19  Cytokine Storm  Drugs In clInic  Drugs In Development  Sars-cov-2  
A Therapeutic Journey of Potential Drugs Against COVID-19 Journal article
Ali, Fayaz, Hussain, Shahid, Zhu, Yi Z.. A Therapeutic Journey of Potential Drugs Against COVID-19[J]. Mini-Reviews in Medicinal Chemistry, 2022, 22(14), 1876-1894.
Authors:  Ali, Fayaz;  Hussain, Shahid;  Zhu, Yi Z.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:3.3/3.7 | Submit date：2023/01/30
Approved Drugs  Clinical Trials  Covid-19 Outbreak  Mers-cov  Pandemic  Therapeutic Agents  
Recent advances in the biosynthesis, structure-activity relationships, formulations, pharmacology, and clinical trials of fisetin Journal article
Zhong, Ruting, Mohamed, Farag, Chen, Meiwan, He, Chengwei, Xiao, Jianbo. Recent advances in the biosynthesis, structure-activity relationships, formulations, pharmacology, and clinical trials of fisetin[J]. Google scholar, 2022, 3(1-2).
Authors:  Zhong, Ruting;  Mohamed, Farag;  Chen, Meiwan;  He, Chengwei;  Xiao, Jianbo
Favorite | TC[WOS]:28 TC[Scopus]:30 | Submit date：2022/08/29
Bioactivities  Bioavailability  Clinical Trials  Fistein  Formulation  Molecular Mechanism  Pharmacokinetics,  Structure–activity Relationship  
Research Progress on Neuroprotection of Insulin-Like Growth Factor-1 towards Glutamate-Induced Neurotoxicity Review article
2022
Authors:  Ge, Lijun;  Liu, Shuyuan;  Rubin, Limor;  Lazarovici, Philip;  Zheng, Wenhua
Favorite | TC[WOS]:14 TC[Scopus]:18  IF:5.1/6.0 | Submit date：2022/03/04
Animal Models  Clinical Trials  Glutamate-mediated Excitotoxicity  Insulin-like Growth Factor-1  Neuroprotection  Signaling Pathways